Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

72 та иш

Иш: Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

  1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

    Gregory A. Roth, George A. Mensah, Catherine O. Johnson +71

    Шарҳ мақолаCardiovascular Health and Risk FactorsJournal of the American College of Cardiology20208 иқтибос
    ABI

  2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

    François Mach, Colin Baigent, Alberico L. Catapano +87

    Мақола20197 иқтибос
    ABI

  3. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L.J. Visseren, François Mach, Yvo M. Smulders +97

    Мақола20217 иқтибос
    ABI

  4. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

    Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries +26

    Мақола20136 иқтибос
    ABI

  5. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

    Colin Baigent, Anthony Keech, Patricia M. Kearney +8

    Шарҳ мақола20056 иқтибос
    ABI

  6. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

    Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller +9

    Мақола20185 иқтибос
    ABI

  7. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

    William T. Friedewald, Robert I. Levy, Donald S. Fredrickson

    Мақола19725 иқтибос
    ABI

  8. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A. Ference, Henry N. Ginsberg, Ian Graham +23

    Шарҳ мақола20174 иқтибос
    ABI

  9. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    Albert Wiegman, Samuel S. Gidding, Gerald F. Watts +29

    Шарҳ мақола20154 иқтибос
    ABI

  10. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

    Florian Kronenberg, Samia Mora, Erik S.G. Stroes +19

    Мақола20223 иқтибос
    ABI

  11. Nonadherence to statins: individualized intervention strategies outside the pill box

    Peter Lansberg, André Lee, Zhen-Vin Lee +2

    Шарҳ мақола20183 иқтибос
    ABI

  12. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

    Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano +18

    Мақола20152 иқтибос
    ABI

  13. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    M. Cuchel, Éric Bruckert, H. N. Ginsberg +41

    Мақола20142 иқтибос
    ABI

  14. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini +37

    Шарҳ мақола20152 иқтибос
    ABI

  15. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

    Anne Langsted, Pia R. Kamstrup, Marianne Benn +2

    Мақола20162 иқтибос
    ABI

  16. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification

    Joana Rita Chora, Michael A. Iacocca, Lukáš Tichý +25

    Мақола20212 иқтибос
    ABI

  17. Recommendations for reporting results of diagnostic genomic testing

    Zandra C. Deans, Joo Wook Ahn, Isabel M. Carreira +7

    Мақола20222 иқтибос
    ABI

  18. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease

    Berit Storgaard Hedegaard, Christian Sørensen Bork, Morten Kaltoft +5

    Мақола20222 иқтибос
    ABI

  19. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    Marina Cuchel, Frederick J. Raal, Robert A. Hegele +20

    Мақола20232 иқтибос
    ABI

  20. High Lipoprotein(a) May Explain One-Quarter of Clinical Familial Hypercholesterolemia Diagnoses in Danish Lipid Clinics

    Berit Storgaard Hedegaard, Børge G. Nordestgaard, Helle Kanstrup +15

    Мақола20232 иқтибос
    ABI

  21. Proposal of a familial hypercholesterolemia paediatric diagnostic score (FH-PeDS)

    Jan Kafol, Beatriz Miranda, Rok Sikonja +11

    Мақола20252 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI